Pfizer

PfizerAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

www.pfizer.com

Pfizer RSS Channel

Display # 
Title Published Date
Pfizer completes acquisition of Anacor 24 June 2016
Help Pfizer change the future of healthy aging 21 June 2016
Pfizer presents promising data from next generation ALK/ROS1 inhibitor in advanced non-small cell lung cancer 06 June 2016
Merck and Pfizer to present Avelumab data in seven different cancers at ASCO annual meeting 19 May 2016
Pfizer awards more than $1 million in metastatic breast cancer research funding 13 May 2016
Pfizer reports first-quarter 2016 results 03 May 2016
Pfizer announces termination of proposed combination with Allergan 07 April 2016
Bristol-Myers Squibb and Pfizer announce global real-world data program and present new analyses of Eliquis (apixaban) 30 March 2016
Pfizer celebrates a year of achievements in 2015 annual review 16 March 2016
Pfizer commences $5 billion accelerated share repurchase 11 March 2016
Merck, Pfizer and Verastem announce combination trial of avelumab and VS-6063 in ovarian cancer 04 March 2016
Pfizer names executive leadership team for combined organization upon close of proposed Allergan transaction 08 February 2016
Bristol-Myers Squibb and Pfizer sign collaboration with Portola Pharmaceuticals 02 February 2016
Pfizer expands R&D equity investment strategy to access early-stage scientific innovations 13 January 2016
Merck KGaA, Darmstadt, Germany, Pfizer and Syndax announce collaboration to evaluate combination of Avelumab and Entinostat in ovarian cancer 04 January 2016
Global partners announce donation of 500 millionth dose of azithromycin 17 November 2015
Pfizer expands its patient assistance program 10 November 2015
Pfizer completes acquisition of Nimenrix and Mencevax from GlaxoSmithKline 06 October 2015
New Centrum® VitaMints® offer a refreshingly new way to take a multivitamin 24 September 2015
Pfizer and Synthon enter into U.S. commercialization agreement for potential generic treatment of multiple sclerosis 04 August 2015

Most Popular Now

AstraZeneca licenses Zurampic to Gr…

AstraZeneca today announced that it has entered into a licensing agreement with Grünenthal GmbH for the exclusive rights to Zurampic (lesinurad) in Europe and Latin Ameri...

Read more

Pfizer presents promising data from…

Pfizer Inc. (NYSE:PFE) today announced encouraging new data from a Phase 1/2 study of lorlatinib, the proposed generic name for PF-06463922, Pfizer's investigational, nex...

Read more

Bayer Science & Education Found…

Applications for the Bayer Science & Education Foundation's international scholarship programs are now being accepted for this year's round. In the academic sector, ambit...

Read more

Merck Accelerator expands its reach…

Merck, a leading science and technology company, has started this week the application period for the next round of its Accelerator programs in Darmstadt, Germany, and Na...

Read more

Call for Abstracts: DIA EuroMeeting…

29 - 31 March 2017, Glasgow, UK. The DIA EuroMeeting 2017 provides a platform for experts from all relevant disciplines within the entire healthcare development and acce...

Read more

AstraZeneca enters commercialisatio…

AstraZeneca today announced it has entered into a commercialisation agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, for rights to its global anae...

Read more

Merck announces survey results expl…

Merck, a leading science and technology company, today announced survey results of 250 global biopharmaceutical executives on how their companies will manage new risks as...

Read more

FDA targets unlawful internet sales…

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, announced that it took action this week against 4,402 we...

Read more

Boehringer Ingelheim and Harvard sc…

Boehringer Ingelheim today announced it has established a research collaboration with the Harvard Stem Cell Institute's - Harvard Fibrosis Network to discover new ways of...

Read more

Promising treatment prospects for i…

In Switzerland alone, more than 5,700 women are diagnosed with breast cancer each year, and almost 1,400 of those affected die of the disease. In many very invasive forms...

Read more

New class of protein could treat ca…

A protein designed by researchers at Georgia State University can effectively target a cell surface receptor linked to a number of diseases, showing potential as a therap...

Read more

Digital health: A way for pharma co…

Pharmaceutical companies have an opportunity to use their expertise to play a greater role in healthcare reform, while also revamping their business model. We believe t...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]